Double cerebral embolic protection: Is more less?

Robert D Safian1

  • 1Department of Cardiovascular Medicine, Beaumont Health, Royal Oak, Michigan.

Insights

Carotid artery stenting (CAS) can cause atheroemboli. Double embolic protection devices (EPDs) may reduce stroke risk in high-risk patients, but more research is needed to confirm their superiority.

Area of Science:

  • Cardiovascular Surgery
  • Neurology
  • Medical Devices

Background:

  • Carotid artery stenting (CAS) procedures carry a risk of atheroembolization from the aorta, arch, or carotid artery.
  • Embolic protection devices (EPDs) are utilized during CAS to mitigate stroke risk associated with atheroembolization.
  • High-risk patients and complex lesions may benefit from dual EPDs, employing both proximal and distal protection.

Discussion:

  • The use of double EPDs (proximal and distal) during CAS is explored as a strategy to enhance safety.
  • Atheroemboli, a significant concern in CAS, can originate from various points within the cerebrovascular system.
  • The potential for double EPDs to offer superior protection compared to single EPDs warrants further investigation.

Key Insights:

  • Embolic protection devices (EPDs) aim to reduce stroke incidence during carotid artery stenting (CAS).
  • Dual EPD systems, encompassing both proximal and distal placement, show potential for improved outcomes in select patient populations.
  • The clinical efficacy of double EPDs versus single EPDs requires additional research.

Outlook:

  • Further clinical trials are necessary to definitively establish the superiority of double EPDs over single EPDs.
  • Comparative studies evaluating different EPD strategies are crucial for optimizing patient safety during CAS.
  • Future research should focus on identifying specific patient and lesion characteristics that predict benefit from double EPD use.